Ian D Jones, Deirdre A Lane, Robyn R Lotto, David Oxborough, Lis Neubeck, Peter E Penson, Emma Johnston Smith, Aimeris Santos, Emily E McGinn, Aderonke Ajiboye, Nicola Town, Gabriela Czanner, Andy Shaw, Hala El-Masri, Gregory Y H Lip
BACKGROUND: Atrial fibrillation (AF) increases the risk of death, stroke, heart failure, cognitive decline, and healthcare costs but is often asymptomatic and undiagnosed. There is currently no national screening programme for AF. The advent of validated hand-held devices allows AF to be detected in non-healthcare settings, enabling screening to be undertaken within the community. METHOD AND RESULTS: In this novel observational study, we embedded a MyDiagnostick single lead ECG sensor into the handles of shopping trolleys in four supermarkets in the Northwest of England: 2155 participants were recruited...
February 21, 2024: American Heart Journal